Saturday, July 27, 2013

Better Dividend: Pfizer vs. Bristol-Myers Squibb

Picking great dividend stocks isn't about just finding the highest-paying yields. The best stocks offer great dividends along with a steady outlook and a secure financial base. Big Pharma's traditionally been home to several strong dividend stocks, with some offering up chart-topping yields.

Just which of Big Pharma's stocks offers your portfolio the best dividend? Motley Fool contributor Dan Carroll below compares two of the industry's biggest names, Pfizer (NYSE: PFE  ) and Bristol-Myers Squibb (NYSE: BMY  ) and shows you which of these two titans is the better pick for long-term investors searching for a great dividend.

One of the best parts of owning big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.

No comments:

Post a Comment